BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 6449368)

  • 1. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors.
    Yamada M; Nakagawa H; Fukushima M; Shimizu K; Hayakawa T; Ikenaka K
    J Neurooncol; 1998 Apr; 37(2):115-21. PubMed ID: 9524089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of duration of exposure to 5-fluorouracil on antiproliferating activity against cultured murine lymphoma cells.
    Kanzawa F; Hoshi A; Kuretani K
    Br J Cancer; 1981 Nov; 44(5):757-9. PubMed ID: 7317275
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.
    Kanzawa F; Hoshi A; Kuretani K; Saneyoshi M; Kawaguchi T
    Cancer Chemother Pharmacol; 1981; 6(1):19-23. PubMed ID: 6456083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of the murine lymphoma L5178Y cell line highly resistant to 5-fluorouracil.
    Kanzawa F; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1980 Aug; 3(8):390-4. PubMed ID: 6451684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
    Yoshida M; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cytotoxicity of 5-fluorouracil: distinction between the irreversible cytotoxic effect of 5-fluorouridine and the reversible cytotoxic effect of 5-fluoro-2'-deoxyuridine on murine lymphoma L5178Y cells in culture.
    Kanzawa F; Hoshi A; Kuretani K
    J Cancer Res Clin Oncol; 1980; 98(1):85-90. PubMed ID: 6450213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias.
    Kessel D; Bruns R; Hall TC
    Mol Pharmacol; 1971 Mar; 7(2):117-21. PubMed ID: 4256648
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorinated pyrimidines. XXIX. Syntheses of 2',3'-dehydro-5-fluoro-2'-deoxyuridine and 2',3'-dideoxy-5-fluorouridine.
    Khwaja TA; Heidelberger C
    J Med Chem; 1967 Nov; 10(6):1066-70. PubMed ID: 4293494
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineoplastic effect of L-asparaginase].
    Opolski A
    Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems.
    Kanzawa F; Hoshi A; Kuretani K
    Eur J Cancer (1965); 1980 Aug; 16(8):1087-92. PubMed ID: 6449368
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.